January 25-26, 2019
InterContinental Miami
100 Chopin Plaza
Miami, FL 33131

Only practicing US and Canadian interventional cardiologists are eligible to participate.
There is no cost to apply.

Supported through educational grants from:

MAJOR BENEFACTORS 
Abbott, ABIOMED, Inc., Boston Scientific Corporation

BENEFACTORS 
Asahi Intecc USA, Inc., Cardiovascular Systems, Inc., Cordis, a Cardinal Health Company, Medtronic, Ostial Corporation, Philips, Teleflex

Overview

This program is geared toward interventionalists seeking to increase their knowledge on the evaluation and comprehensive management of complex and higher-risk patients with an indication for coronary revascularization (due to symptoms or prognosis). Emphasizing a case-based presentation format with audience interactivity, participants will learn how to assess and plan indicated procedures, from clinical decision-making regarding when/how to perform revascularization, and including discussions from access through post-procedural care. Specific issues regarding the treatment of complex lesions will be addressed, with attention to the treatment of calcified lesions, bifurcation disease, chronic total occlusions, in-stent restenosis, and coronary artery disease in the post-CABG setting. In addition, the optimal use of adjunctive tools such as imaging, physiology, atherectomy, and hemodynamic support will be addressed. The use of hands-on training will further enhance the learning experience. Expert faculty will offer insights into selecting patients and devices, optimizing technique, and overcoming difficult anatomy.

Learning Objectives

By the end of this program, participants
will be able to:

  • Elucidate a conceptual framework for assessing the indications for coronary revascularization in higher-risk patients.
  • Learn new techniques and develop further knowledge of device selection in managing patients with complex coronary artery disease.
  • Discuss the different case scenarios in which specific advanced techniques will provide an adequate risk/benefit ratio for patients.
This educational activity is designed for practicing US and Canadian interventional cardiologists and clinical cardiologists involved in the management of patients with cardiovascular disease.
Evaluation by questionnaire will address content, presentation effectiveness, possible bias, and future educational needs.

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.


Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation, nor the course directors of this activity.


Faculty participating in medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty in noncompliance with this policy are not permitted to participate in this activity.

This program is sponsored by the Cardiovascular Research Foundation. The Cardiovascular Research Foundation gratefully acknowledges the following supporters for this program:

MAJOR BENEFACTORS 
Abbott, ABIOMED, Inc., Boston Scientific Corporation

BENEFACTORS 
Asahi Intecc USA, Inc., Cardiovascular Systems, Inc., Cordis, a Cardinal Health Company, Medtronic, Ostial Corporation, Philips, Teleflex

The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience.

Only practicing US and Canadian interventional cardiologists are eligible to participate. Travel and hotel support will be provided to accepted applicants who fully participate in the program per the acceptance guidelines. There is no cost to apply. This program is not CME accredited.

This activity is not CME accredited, and therefore, the supporter is required under the Sunshine Act (as part of the Affordable Care Act) to track and report all payments and transfers of value to US licensed physicians, including meals and expenses that are provided to you. In order to help supporters comply with the Sunshine Act, the names and contact information of all US and Canadian licensed physicians participating in this function will be provided to the supporter of this program. The information provided will be used for reporting purposes only.


Should you partake in this program, you will be reported as part of the Sunshine Act submission and will appear on the CMS Open Payments website on the next reporting cycle.


VERMONT-LICENSED HCPs

Vermont laws prohibit this program from providing any complimentary food, meals, or refreshments to healthcare professionals licensed by and regularly practicing in Vermont. Accordingly, healthcare professionals licensed by and practicing in Vermont are requested not to apply for this program.

Faculty

CHAIRS


{{chair.full_name}}, {{chair.degree}} {{chair.medical_institution}}
{{chair.address}}

INVITED FACULTY


{{faculty.full_name}}, {{faculty.degree}} {{faculty.medical_institution}}
{{faculty.address}}

Agenda

{{key2}}

{{formatMomentDate(session.datetime_start, 'h:mm a')}} {{session.title}}
 

{{session.title}}

{{moderator.role.name_plural}}: {{person.full_name}}{{$last ? '' : ', '}}
{{formatMomentDate(presentation.datetime_start, 'h:mm a')}} {{presentation.title}}
{{moderator.role.name}}: {{person.full_name}}{{$last ? '' : ', '}}

APPLY

There is no cost to apply.

Should you have any questions, please contact Danielle Betts at dbetts@crf.org.

Apply TODAY